Curative drug for neurodegenerative diseases
OwnerSatoru Sugiyama, Tokutaro Miki +1inventors
InventorsSatoru Sugiyama, Tokutaro Miki, Hiroshi Nishikawa
Life of this patent
Estimating the term…
Abstract
A compound is prepared based on Formula 1: wherein, R1 represents an alkyl group with a carbon number of 4 to 8, and R2 represents a hydrogen atom, alkylcarbonyl group with a carbon number of 2 to 6 or alkoxycarbonyl group with a carbon number of 2 to 6. A curative drug for neurodegenerative diseases can be prepared principally from the compound or a hydroquinone derivative consisting of a cyclodextrin inclusion compound thereof. The curative drug for neurodegenerative diseases has a safe and beneficial effect of inhibiting nerve cell disorder due to oxidative stress, thereby to stop progression of symptoms.
Claims3
1-2. (canceled)
A method for treating a neurodegenerative disease which comprises administering, to a patient in need thereof, a therapeutically effective amount of a compound represented by Formula 1 or a hydroquinone derivative consisting of a cyclodextrin inclusion compound thereof:
- wherein, R1 represents an alkyl group with a carbon number of 4 to 8, and R2 represents a hydrogen atom, alkylcarbonyl group with a carbon number of 2 to 6 or alkoxycarbonyl group with a carbon number of 2 to 6.
Dependencies are inferred from the claim text.